Code HS: 30
Pays | |
La direction de la | |
Pays | |
Période | |
Sélection de produits |
Période | Somme |
---|---|
2020 | $28.2 k |
Total: | $28.2 k |
Période | Poids, tonnes. |
---|---|
2020 | 0.006 |
Total: | 0.006 |
Famille de produits | 2020 | 2020 | ch. | ∑ (2020-2020) | Part |
---|---|---|---|---|---|
06 3001: Glandes et autres organes à usages opothérapiques | --- | --- | --- | --- | 0% |
06 3002: Sang humain; sang animal; vaccins, toxines, cultures de micro-organismes | --- | --- | --- | --- | 0% |
06 3003: Médicaments | --- | --- | --- | --- | 0% |
06 3004: Médicaments constitués par des produits mélangés ou non mélangés | $28.2 k | $28.2 k | 0% | $28.2 k | 100% |
06 3005: Ouates, gazes, bandes et articles analogues | --- | --- | --- | --- | 0% |
06 3006: Préparations et articles pharmaceutiques visés à la note 4 du présent chapitre | --- | --- | --- | --- | 0% |
Total: | $28.2 k | $28.2 k | $28.2 k |
№ | Pays | ∑ (2020-2020) | Part |
---|---|---|---|
1 | Bélarus | $16.1 M | 43.3% |
2 | États-Unis | $10.6 M | 28.4% |
3 | Espagne | $5.2 M | 14% |
4 | Italie | $3.4 M | 9.1% |
5 | Allemagne | $798 k | 2.1% |
6 | Pays-Bas | $349 k | 0.9% |
7 | Royaume-Uni | $298 k | 0.8% |
8 | Japon | $150 k | 0.4% |
9 | Canada | $123 k | 0.3% |
10 | Ukraine | $63.4 k | 0.2% |
11 | Belgique | $39.6 k | 0.1% |
12 | Irlande | $28.2 k | 0.1% |
13 | Inde | $22.9 k | 0.1% |
14 | Suisse | $16 k | 0% |
15 | France | $3.33 k | 0% |
16 | Arménie | $1.64 k | 0% |
17 | Kazakhstan | $1.52 k | 0% |
18 | Tadjikistan | $451 | 0% |
19 | Israël | $106 | 0% |
Le total de tous les pays: | $37.3 M | 100% |
№ | Région | ∑ (2020-2020) | Part |
---|---|---|---|
1 | Moskva | $571 M | 79.7% |
2 | Moskovskaya oblast | $68.1 M | 9.5% |
3 | Nijegorodskaya oblast | $43.8 M | 6.1% |
4 | Kurskaya oblast | $28.2 M | 3.9% |
5 | Bashkiriya | $3.3 M | 0.5% |
6 | Sankt-Peterburg | $1.8 M | 0.3% |
7 | Sverdlovskaya oblast | $49 k | 0% |
8 | Smolenskaya oblast | $28.2 k | 0% |
9 | Kaliningradskaya oblast | $1.67 k | 0% |
10 | Rostovskaya oblast | $1 k | 0% |
Dans toutes les régions: | $716 M | 100% |